1. Home
  2. DXR
  3. DXR News

Latest Daxor Corporation (DXR) News on November 27, 2025

Daxor Fuels Growth with Three New Facility Adoptions and Deployment of Next-Generation BVA Analyzer
DXR

GlobeNewswire

2 days ago

Daxor Fuels Growth with Three New Facility Adoptions and Deployment of Next-Generation BVA Analyzer

Daxor CEO Michael Feldschuh to Engage Investors at Exclusive Maxim Growth Summit
DXR

GlobeNewswire

a month ago

Daxor CEO Michael Feldschuh to Engage Investors at Exclusive Maxim Growth Summit

Daxor’s New BVA Technology To Be Showcased At MedAxiom CV Transforum Fall '25
DXR

GlobeNewswire

a month ago

Daxor’s New BVA Technology To Be Showcased At MedAxiom CV Transforum Fall '25

Daxor Announces Duke University Study on Blood Volume Analysis in Heart Failure Published in American Heart Journal
DXR

GlobeNewswire

6 months ago

Daxor Announces Duke University Study on Blood Volume Analysis in Heart Failure Published in American Heart Journal

Daxor's Blood Volume Analysis Diagnostic Reaches Two New U.S. Healthcare Systems
DXR

GlobeNewswire

6 months ago

Daxor's Blood Volume Analysis Diagnostic Reaches Two New U.S. Healthcare Systems

Florida Healthcare Leader Embraces Daxor Blood Volume Analysis Technology
DXR

GlobeNewswire

7 months ago

Florida Healthcare Leader Embraces Daxor Blood Volume Analysis Technology

Three New Medical Centers Adopt Daxor's Blood Volume Diagnostic Signaling Growing Clinical Acceptance
DXR

GlobeNewswire

7 months ago

Three New Medical Centers Adopt Daxor's Blood Volume Diagnostic Signaling Growing Clinical Acceptance

Daxor Corporation to Exhibit at the 45th International Society for Heart and Lung Transplant (ISHLT) Annual Meeting and Scientific Sessions
DXR

GlobeNewswire

7 months ago

Daxor Corporation to Exhibit at the 45th International Society for Heart and Lung Transplant (ISHLT) Annual Meeting and Scientific Sessions

Daxor Corporation to Showcase Innovative Blood Volume Analysis at MedAxiom Cardiovascular Transforum Spring 2025
DXR

GlobeNewswire

7 months ago

Daxor Corporation to Showcase Innovative Blood Volume Analysis at MedAxiom Cardiovascular Transforum Spring 2025

New Research at ACC25 Shows Daxor BVA-Identified Euvolemic Heart Failure Patients Experience 2.61 Times Better Survival
DXR

GlobeNewswire

7 months ago

New Research at ACC25 Shows Daxor BVA-Identified Euvolemic Heart Failure Patients Experience 2.61 Times Better Survival

Daxor Corporation Submits 510(k) to FDA for Next-Generation Blood Volume Analyzer
DXR

GlobeNewswire

8 months ago

Daxor Corporation Submits 510(k) to FDA for Next-Generation Blood Volume Analyzer

Daxor Corporation Announces New Data from Duke University and Highlights Key BVA Insights at American College of Cardiology’s 74th Annual Scientific Session and Expo
DXR

GlobeNewswire

8 months ago

Daxor Corporation Announces New Data from Duke University and Highlights Key BVA Insights at American College of Cardiology’s 74th Annual Scientific Session and Expo

Daxor Expands Blood Volume Analysis Technology Across Midwest, Wisconsin, and New Jersey Healthcare Networks
DXR

GlobeNewswire

8 months ago

Daxor Expands Blood Volume Analysis Technology Across Midwest, Wisconsin, and New Jersey Healthcare Networks

Daxor Corporation Reports Increase in NAV to $7.25 Per Share and 116.5 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2024
DXR

GlobeNewswire

9 months ago

Daxor Corporation Reports Increase in NAV to $7.25 Per Share and 116.5 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2024

Daxor Corporation to Host Investor Conference Call to Discuss Fiscal Year 2024 Financial Results and Provide a Corporate Update on March 6, 2025
DXR

GlobeNewswire

9 months ago

Daxor Corporation to Host Investor Conference Call to Discuss Fiscal Year 2024 Financial Results and Provide a Corporate Update on March 6, 2025

Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
DXR

GlobeNewswire

9 months ago

Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders

Daxor Corporation Reports Increase in NAV to $7.25 Per Share and 116.5 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023
DXR

GlobeNewswire

9 months ago

Daxor Corporation Reports Increase in NAV to $7.25 Per Share and 116.5 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023

Daxor Expands Blood Volume Analysis Services at Major Midwest Healthcare Center
DXR

GlobeNewswire

9 months ago

Daxor Expands Blood Volume Analysis Services at Major Midwest Healthcare Center

Daxor Corporation Expands Blood Volume Analysis Technology to Major New Jersey Hospitals
DXR

GlobeNewswire

9 months ago

Daxor Corporation Expands Blood Volume Analysis Technology to Major New Jersey Hospitals

Daxor Corporation Announces New Data on Blood Volume Analysis from Duke and Yale Universities Presented at THT 2025
DXR

GlobeNewswire

9 months ago

Daxor Corporation Announces New Data on Blood Volume Analysis from Duke and Yale Universities Presented at THT 2025

Daxor to Exhibit at World's Largest Critical Care Conference
DXR

GlobeNewswire

9 months ago

Daxor to Exhibit at World's Largest Critical Care Conference

Daxor's Blood Volume Analysis Uncovers Hidden Heart Failure Subtype in Nearly 1 in 5 Patients, Enabling Targeted Treatment
DXR

GlobeNewswire

9 months ago

Daxor's Blood Volume Analysis Uncovers Hidden Heart Failure Subtype in Nearly 1 in 5 Patients, Enabling Targeted Treatment

New Multicenter Study Highlights Utility of Daxor’s Blood Volume Analysis in Heart Failure Care
DXR

GlobeNewswire

9 months ago

New Multicenter Study Highlights Utility of Daxor’s Blood Volume Analysis in Heart Failure Care

Daxor Expands Its BVA-100™ Blood Volume Diagnostic to Two New Hospital Systems Adding to Sales Momentum
DXR

GlobeNewswire

a year ago

Daxor Expands Its BVA-100™ Blood Volume Diagnostic to Two New Hospital Systems Adding to Sales Momentum

DAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL '24
DXR

GlobeNewswire

a year ago

DAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL '24

Daxor Corporation to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
DXR

GlobeNewswire

a year ago

Daxor Corporation to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device
DXR

GlobeNewswire

a year ago

Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device

Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024
DXR

GlobeNewswire

a year ago

Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024

Newly Published Review Highlights the Pivotal Role of Daxor’s Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome Management
DXR

GlobeNewswire

a year ago

Newly Published Review Highlights the Pivotal Role of Daxor’s Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome Management

Daxor Corporation Receives $300K Matching Fund Award From Launch Tennessee
DXR

GlobeNewswire

a year ago

Daxor Corporation Receives $300K Matching Fund Award From Launch Tennessee

Leading Central Florida Hospital Implements Daxor’s BVA-100™ Blood Volume Diagnostic for Heart Failure Patient Care
DXR

GlobeNewswire

a year ago

Leading Central Florida Hospital Implements Daxor’s BVA-100™ Blood Volume Diagnostic for Heart Failure Patient Care

Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter
DXR

GlobeNewswire

a year ago

Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter

Daxor Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference
DXR

GlobeNewswire

a year ago

Daxor Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Daxor Corporation Announces Launch of BVA Program at Mid-South Largest Integrated Network
DXR

GlobeNewswire

a year ago

Daxor Corporation Announces Launch of BVA Program at Mid-South Largest Integrated Network

Daxor Corporation Awarded $1.9M Contract by The U.S. Air Force for Development of its Next Generation Tracer System in its Point-of-Care Blood Volume Analyzer
DXR

GlobeNewswire

a year ago

Daxor Corporation Awarded $1.9M Contract by The U.S. Air Force for Development of its Next Generation Tracer System in its Point-of-Care Blood Volume Analyzer

Daxor Expands To Three New Facilities As Blood Volume Analysis Technology Gains Momentum Nationwide
DXR

GlobeNewswire

a year ago

Daxor Expands To Three New Facilities As Blood Volume Analysis Technology Gains Momentum Nationwide

Daxor Corporation Awarded New U.S. Defense Health Agency Contract for Added Capabilities to Its Point-of-Care Blood Volume Analyzer
DXR

GlobeNewswire

a year ago

Daxor Corporation Awarded New U.S. Defense Health Agency Contract for Added Capabilities to Its Point-of-Care Blood Volume Analyzer

Daxor Corporation’s BVA-100™ Blood Volume Diagnostic Expands to Three New Centers, Gains Traction Nationwide
DXR

GlobeNewswire

a year ago

Daxor Corporation’s BVA-100™ Blood Volume Diagnostic Expands to Three New Centers, Gains Traction Nationwide

Daxor Corporation to Showcase the Benefits of BVA-100™ Guided-Care at the American Association of Heart Failure Nurses (AAHFN) 20th Annual Meeting
DXR

GlobeNewswire

a year ago

Daxor Corporation to Showcase the Benefits of BVA-100™ Guided-Care at the American Association of Heart Failure Nurses (AAHFN) 20th Annual Meeting

Daxor Corporation Appoints John L. Jefferies, M.D. as Chief Medical Officer
DXR

GlobeNewswire

a year ago

Daxor Corporation Appoints John L. Jefferies, M.D. as Chief Medical Officer

New Studies Prove the Clinical Benefits of Daxor’s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of Congestion
DXR

GlobeNewswire

2 years ago

New Studies Prove the Clinical Benefits of Daxor’s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of Congestion

DAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE SPRING’24 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100™)
DXR

GlobeNewswire

2 years ago

DAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE SPRING’24 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100™)

Daxor Corporation Announces New Hospital Account at Leading Chicago Hospital
DXR

GlobeNewswire

2 years ago

Daxor Corporation Announces New Hospital Account at Leading Chicago Hospital

Daxor Corporation to Exhibit at the American College of Cardiology for ACC.24
DXR

GlobeNewswire

2 years ago

Daxor Corporation to Exhibit at the American College of Cardiology for ACC.24

Daxor Corporation (NASDAQ:DXR) Q4 2023 Earnings Call Transcript
DXR

Insider Monkey

2 years ago

Daxor Corporation (NASDAQ:DXR) Q4 2023 Earnings Call Transcript

Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics
DXR

GlobeNewswire

2 years ago

Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics

Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024
DXR

GlobeNewswire

2 years ago

Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024

Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
DXR

GlobeNewswire

2 years ago

Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders

Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023
DXR

GlobeNewswire

2 years ago

Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023

Daxor Announces Sales to Three New Hospitals Furthering Expansion of Its User Base
DXR

GlobeNewswire

2 years ago

Daxor Announces Sales to Three New Hospitals Furthering Expansion of Its User Base

Multi-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor’s Unique Clinical Utility for Heart Failure Patients
DXR

GlobeNewswire

2 years ago

Multi-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor’s Unique Clinical Utility for Heart Failure Patients

Daxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics Conference
DXR

GlobeNewswire

2 years ago

Daxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics Conference

Daxor Corporation Starts 2024 with Ongoing Growth in New Blood Volume Analyzer Acquisitions
DXR

GlobeNewswire

2 years ago

Daxor Corporation Starts 2024 with Ongoing Growth in New Blood Volume Analyzer Acquisitions

Daxor Corporation Closes Q4 2023 with Growth in New Sales to Hospital Systems and Increased Utilization of its BVA-100® Blood Volume Diagnostic Across the U.S. at Existing Accounts
DXR

GlobeNewswire

2 years ago

Daxor Corporation Closes Q4 2023 with Growth in New Sales to Hospital Systems and Increased Utilization of its BVA-100® Blood Volume Diagnostic Across the U.S. at Existing Accounts

Daxor Corporation to Exhibit at the Society of Nuclear Medicine and Molecular Imaging Mid-Winter and American College Nuclear Medicine Annual Meeting
DXR

GlobeNewswire

2 years ago

Daxor Corporation to Exhibit at the Society of Nuclear Medicine and Molecular Imaging Mid-Winter and American College Nuclear Medicine Annual Meeting

Home Federal Bancorp of Louisiana Second Quarter 2024 Earnings: EPS: US$0.33 (vs US$0.57 in 2Q 2023)
DXR

Simply Wall St.

2 years ago

Home Federal Bancorp of Louisiana Second Quarter 2024 Earnings: EPS: US$0.33 (vs US$0.57 in 2Q 2023)

Space Race Speculation: 3 Stocks Soaring in the New Frontier
DXR

InvestorPlace

2 years ago

Space Race Speculation: 3 Stocks Soaring in the New Frontier

DXR

GlobeNewswire

2 years ago

SB Financial Group Announces Fourth Quarter and Full Year 2023 Results

MAGYAR BANCORP, INC. ANNOUNCES FIRST QUARTER FINANCIAL RESULTS AND DECLARES DIVIDEND
DXR

PR Newswire

2 years ago

MAGYAR BANCORP, INC. ANNOUNCES FIRST QUARTER FINANCIAL RESULTS AND DECLARES DIVIDEND

Clean Energy Technologies Continues Normal Operations Among Stock Volatility
DXR

GlobeNewswire

2 years ago

Clean Energy Technologies Continues Normal Operations Among Stock Volatility

Flexsteel Industries (FLXS) Just Flashed Golden Cross Signal: Do You Buy?
DXR

Zacks

2 years ago

Flexsteel Industries (FLXS) Just Flashed Golden Cross Signal: Do You Buy?

Chuck Royce Reduces Stake in Amtech Systems Inc
DXR

GuruFocus.com

2 years ago

Chuck Royce Reduces Stake in Amtech Systems Inc

Industry-Recognized Technology Leader Joins DLH as Strategic Advisor
DXR

GlobeNewswire

2 years ago

Industry-Recognized Technology Leader Joins DLH as Strategic Advisor

DXR

Zacks Small Cap Research

2 years ago

AIXI: Initiating Coverage – The AI hype cycle subsides but opportunities and challenges lie ahead in 2024

Acurx Pharmaceuticals to Present at the Microcap Conference, January 31, 2024 - February 1, 2024
DXR

PR Newswire

2 years ago

Acurx Pharmaceuticals to Present at the Microcap Conference, January 31, 2024 - February 1, 2024

REE Completes U.S. Certification of Full-by-Wire Vehicles and Begins Customer Deliveries of its P7-C Electric Truck
DXR

GlobeNewswire

2 years ago

REE Completes U.S. Certification of Full-by-Wire Vehicles and Begins Customer Deliveries of its P7-C Electric Truck

New to The Street Airs on the FOX Business Network, Episode 550, Featuring Six Corporate Interviews, Broadcast Monday, January 22, 2024, at 10:30 PM PT
DXR

GlobeNewswire

2 years ago

New to The Street Airs on the FOX Business Network, Episode 550, Featuring Six Corporate Interviews, Broadcast Monday, January 22, 2024, at 10:30 PM PT

Can Flexsteel (FLXS) Run Higher on Rising Earnings Estimates?
DXR

Zacks

2 years ago

Can Flexsteel (FLXS) Run Higher on Rising Earnings Estimates?

FiscalNote to Present at the 26th Annual Needham Growth Conference
DXR

Business Wire

2 years ago

FiscalNote to Present at the 26th Annual Needham Growth Conference

Daxor Corporation to Exhibit at the Society for Critical Care Medicine 2024 Critical Care Congress
DXR

GlobeNewswire

2 years ago

Daxor Corporation to Exhibit at the Society for Critical Care Medicine 2024 Critical Care Congress

After Plunging -41.57% in 4 Weeks, Here's Why the Trend Might Reverse for Edgio (EGIO)
DXR

Zacks

2 years ago

After Plunging -41.57% in 4 Weeks, Here's Why the Trend Might Reverse for Edgio (EGIO)

Northern Technologies International Corporation (NASDAQ:NTIC) Q4 2023 Earnings Call Transcript
DXR

Insider Monkey

2 years ago

Northern Technologies International Corporation (NASDAQ:NTIC) Q4 2023 Earnings Call Transcript

Northern Technologies International (NASDAQ:NTIC) Could Be Struggling To Allocate Capital
DXR

Simply Wall St.

2 years ago

Northern Technologies International (NASDAQ:NTIC) Could Be Struggling To Allocate Capital

Xiao-I and eRoad Forge Strategic Partnership to Drive Commercialization Through Xiao-I's Hua Zang Ecosystem
DXR

ACCESSWIRE

2 years ago

Xiao-I and eRoad Forge Strategic Partnership to Drive Commercialization Through Xiao-I's Hua Zang Ecosystem

Newswire Unveils its Media Suite, an All-in-One Solution for Media Engagement
DXR

ACCESSWIRE

2 years ago

Newswire Unveils its Media Suite, an All-in-One Solution for Media Engagement

DAXOR AWARDED ADDITIONAL NEW PATENT FOR SMART BLOOD VOLUME GUIDANCE TECHNOLOGY TO IMPROVE TREATMENT AND OUTCOMES
DXR

GlobeNewswire

2 years ago

DAXOR AWARDED ADDITIONAL NEW PATENT FOR SMART BLOOD VOLUME GUIDANCE TECHNOLOGY TO IMPROVE TREATMENT AND OUTCOMES

Beam Global to Present at the 26th Annual Needham Growth Conference
DXR

GlobeNewswire

2 years ago

Beam Global to Present at the 26th Annual Needham Growth Conference

CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California
DXR

PR Newswire

2 years ago

CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California

DXR

Business Wire

2 years ago

Tilly’s, Inc. Announces 2023 Holiday Period Net Sales, Updates Fourth Quarter Outlook

DXR

GlobeNewswire

2 years ago

SB Financial Group, Inc. Announces Schedule for Fourth Quarter and Full Year 2023 Results

Immix Biopharma Announces Dr. Vaishali Sanchorawala, AL Amyloidosis Thought Leader, Director of the Amyloidosis Center at Boston University and Boston Medical Center, Joins Scientific Advisory Board
DXR

GlobeNewswire

2 years ago

Immix Biopharma Announces Dr. Vaishali Sanchorawala, AL Amyloidosis Thought Leader, Director of the Amyloidosis Center at Boston University and Boston Medical Center, Joins Scientific Advisory Board

DXR

Business Wire

2 years ago

Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds

PIMCO Closed-End Funds Declare Monthly Common Share Distributions
DXR

GlobeNewswire

2 years ago

PIMCO Closed-End Funds Declare Monthly Common Share Distributions

Daxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume Analyzer
DXR

GlobeNewswire

2 years ago

Daxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume Analyzer

SB Financial Group (NASDAQ:SBFG) investors are sitting on a loss of 2.4% if they invested three years ago
DXR

Simply Wall St.

2 years ago

SB Financial Group (NASDAQ:SBFG) investors are sitting on a loss of 2.4% if they invested three years ago

CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants
DXR

PR Newswire

2 years ago

CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants

2024 election: $16B expected to be spent on political ads
DXR

Yahoo Finance Video

2 years ago

2024 election: $16B expected to be spent on political ads

Manhattan Bridge Capital, Inc. Announces Payment of Quarterly Dividend
DXR

GlobeNewswire

2 years ago

Manhattan Bridge Capital, Inc. Announces Payment of Quarterly Dividend

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
DXR

GlobeNewswire

2 years ago

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

Electrovaya Begins Shipping Infinity-HV Battery Systems
DXR

ACCESSWIRE

2 years ago

Electrovaya Begins Shipping Infinity-HV Battery Systems

DXR

Business Wire

2 years ago

Tilly’s, Inc. Announces Participation in ICR Conference 2024

Tilly’s, Inc. and Tilly’s Life Center Partner On Round-Up-4-Change Campaign to Continue Helping Teens
DXR

Business Wire

2 years ago

Tilly’s, Inc. and Tilly’s Life Center Partner On Round-Up-4-Change Campaign to Continue Helping Teens

DXR

Business Wire

2 years ago

reAlpha Tech Corp. Enters into Letter of Intent to Acquire United Software Group

DXR

Business Wire

2 years ago

reAlpha Tech Corp. Announces Second Quarter 2023 Results and Provides Business Update

BioAtla Hosting Virtual R&D Day to Highlight BA3071 CAB-CTLA-4 Phase 1 Data in Multiple Solid Tumor Types
DXR

GlobeNewswire

2 years ago

BioAtla Hosting Virtual R&D Day to Highlight BA3071 CAB-CTLA-4 Phase 1 Data in Multiple Solid Tumor Types

Earnings Release: Here's Why Analysts Cut Their Inotiv, Inc. (NASDAQ:NOTV) Price Target To US$12.81
DXR

Simply Wall St.

2 years ago

Earnings Release: Here's Why Analysts Cut Their Inotiv, Inc. (NASDAQ:NOTV) Price Target To US$12.81

DXR

PR Newswire

2 years ago

Ellomay Capital Reports Publication of Financial Statements of Dorad Energy Ltd. for the Three and Nine Month Periods Ended September 30, 2023

DXR

PR Newswire

2 years ago

Ellomay Capital Announces Results of 2023 Annual General Meeting of Shareholders

Calculating The Fair Value Of Strattec Security Corporation (NASDAQ:STRT)
DXR

Simply Wall St.

2 years ago

Calculating The Fair Value Of Strattec Security Corporation (NASDAQ:STRT)

Zepp Health Celebrates 10 Years of Innovation with a Purpose-Led Brand Refresh and Expanded Wellness Healthcare Solutions
DXR

Business Wire

2 years ago

Zepp Health Celebrates 10 Years of Innovation with a Purpose-Led Brand Refresh and Expanded Wellness Healthcare Solutions

Share on Social Networks: